We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRKS icon
1976
United Parks & Resorts
PRKS
$2.09B
$1.08M ﹤0.01%
66,164
-21,982
-25% -$378K
BSCN
1977
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$1.07M ﹤0.01%
51,163
+15,579
+44% +$326K
MAV
1978
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$1.07M ﹤0.01%
91,486
+5,768
+7% +$65.9K
BSCI
1979
DELISTED
Invesco BulletShares 2018 Corporate Bond ETF
BSCI
$1.07M ﹤0.01%
50,278
+16,065
+47% +$341K
PSLV icon
1980
Sprott Physical Silver Trust
PSLV
$12.8B
$1.06M ﹤0.01%
168,809
-3,600
-2% -$23.5K
LNCE
1981
DELISTED
Snyders-Lance, Inc.
LNCE
$1.06M ﹤0.01%
30,726
+667
+2% +$24.3K
NGL icon
1982
NGL Energy Partners
NGL
$2.17B
$1.06M ﹤0.01%
75,894
+27,304
+56% +$437K
PMM
1983
Franklin Managed Municipal Income Trust
PMM
$270M
$1.06M ﹤0.01%
141,242
-1,501
-1% -$11.2K
JDD
1984
DELISTED
Nuveen Diversified Dividend and Income Fund
JDD
$1.06M ﹤0.01%
83,446
-6,365
-7% -$78.8K
RYN icon
1985
Rayonier
RYN
$6.45B
$1.06M ﹤0.01%
40,599
-13,367
-25% -$344K
IMAX icon
1986
IMAX
IMAX
$2.73B
$1.06M ﹤0.01%
48,156
-611
-1% -$17.1K
CUBE icon
1987
CubeSmart
CUBE
$9.42B
$1.05M ﹤0.01%
43,801
-13,866
-24% -$351K
LGND icon
1988
Ligand Pharmaceuticals
LGND
$6.02B
$1.05M ﹤0.01%
13,888
+357
+3% +$25K
VONG icon
1989
Vanguard Russell 1000 Growth ETF
VONG
$44.7B
$1.05M ﹤0.01%
34,552
+3,460
+11% +$104K
THRM icon
1990
Gentherm
THRM
$1.24B
$1.05M ﹤0.01%
27,055
-621
-2% -$23.2K
PRAH
1991
DELISTED
PRA Health Sciences, Inc.
PRAH
$1.05M ﹤0.01%
13,979
+4,113
+42% +$285K
MTGE
1992
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$1.05M ﹤0.01%
55,771
-4,254
-7% -$76.9K
MTCH icon
1993
Match Group
MTCH
$8.54B
$1.05M ﹤0.01%
60,257
-276
-0.5% -$5.06K
SIMO icon
1994
Silicon Motion
SIMO
$9.07B
$1.04M ﹤0.01%
21,601
-1,241
-5% -$61.4K
NHS
1995
Neuberger High Yield Strategies Fund Inc
NHS
$254M
$1.04M ﹤0.01%
87,443
+6,249
+8% +$74.6K
CORT icon
1996
Corcept Therapeutics
CORT
$11.7B
$1.04M ﹤0.01%
88,028
+42,628
+94% +$463K
TSLX icon
1997
Sixth Street Specialty
TSLX
$1.78B
$1.03M ﹤0.01%
50,609
+5,887
+13% +$121K
HES
1998
DELISTED
Hess
HES
$1.03M ﹤0.01%
23,576
-1,879
-7% -$87.8K
MTG icon
1999
MGIC Investment
MTG
$6.21B
$1.03M ﹤0.01%
91,861
+59,470
+184% +$640K
ACIA
2000
DELISTED
Acacia Communications Inc
ACIA
$1.03M ﹤0.01%
24,818
-6,371
-20% -$306K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.